|Induction of apoptosis by laminarin, regulating the insulin-like growth factor-IR signaling pathways in HT-29 human colon cells.|
|Jump to Full Text|
|PMID: 22859258 Owner: NLM Status: MEDLINE|
|In recent years, algae have been highlighted as potential sources of anticancer agents. Laminarin is a molecule found in marine brown algae that has potentially beneficial biological activities. However, these activities have not been investigated. In the present study, we examined the effects of laminarin on HT-29 cells and analyzed its effect on the insulin-like growth factor (IGF-IR) signaling pathway. 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assays revealed that laminarin induced cell death in a dose-dependent manner. Western blotting showed that laminarin decreased mitogen-activated protein kinases (MAPK) and ERK phosphorylation. Decreased proliferation depended on IGF-IR, which was associated with the downregulation of MAPK/ERK. These results are important for understanding the roles of IGF-IR in colon cancer cell tumorigenesis, and suggest that laminarin shows activity against human colon cancer.|
|Hee-Kyoung Park; In-Hye Kim; Joongkyun Kim; Taek-Jeong Nam|
Related Documents :
|11533228 - Receptor heterodimerization: essential mechanism for platelet-derived growth factor-ind...
17353898 - Egfr kinase domain mutations - functional impact and relevance for lung cancer therapy.
1674818 - The juxtamembrane regions of the epidermal growth factor receptor and gp185erbb-2 deter...
17486068 - Defective ubiquitinylation of egfr mutants of lung cancer confers prolonged signaling.
9989818 - Rapid dephosphorylation of p107 following uv irradiation.
21730068 - Structural determinants of discrimination of nad+ from nadh in yeast mitochondrial nadh...
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2012-08-02|
|Title: International journal of molecular medicine Volume: 30 ISSN: 1791-244X ISO Abbreviation: Int. J. Mol. Med. Publication Date: 2012 Oct|
|Created Date: 2012-12-17 Completed Date: 2013-05-24 Revised Date: 2013-07-12|
Medline Journal Info:
|Nlm Unique ID: 9810955 Medline TA: Int J Mol Med Country: Greece|
|Languages: eng Pagination: 734-8 Citation Subset: IM|
|Department of Food Science and Nutrition, Pukyong National University, Nam-gu, Busan 608-737, Republic of Korea.|
|APA/MLA Format Download EndNote Download BibTex|
Apoptosis / drug effects*
Colon / cytology, drug effects, metabolism
Colonic Neoplasms / drug therapy*, metabolism
Mitogen-Activated Protein Kinases / metabolism
Phaeophyta / chemistry
Phosphorylation / drug effects
Polysaccharides / pharmacology*
Signal Transduction / drug effects*
Somatomedins / metabolism*
|0/Antineoplastic Agents; 0/Polysaccharides; 0/Somatomedins; 9008-22-4/laminaran; EC 126.96.36.199/Mitogen-Activated Protein Kinases|
Journal ID (nlm-ta): Int J Mol Med
Journal ID (iso-abbrev): Int. J. Mol. Med
Journal ID (publisher-id): IJMM
Publisher: D.A. Spandidos
Copyright © 2012, Spandidos Publications
Received Day: 03 Month: 4 Year: 2012
Accepted Day: 08 Month: 6 Year: 2012
Print publication date: Month: 10 Year: 2012
Electronic publication date: Day: 02 Month: 8 Year: 2012
pmc-release publication date: Day: 02 Month: 8 Year: 2012
Volume: 30 Issue: 4
First Page: 734 Last Page: 738
PubMed Id: 22859258
Publisher Id: ijmm-30-04-0734
|Induction of apoptosis by laminarin, regulating the insulin-like growth factor-IR signaling pathways in HT-29 human colon cells|
1Departments of Food Science and Nutrition
2Biotechnology, Pukyong National University, Nam-gu, Busan 608-737, Republic of Korea
|Correspondence: Correspondence to: Professor Taek-Jeong Nam, Department of Food Science and Nutrition, Pukyong National University 599-1, Daeyeon 3-Dong, Nam-gu, Busan 608-737, Republic of Korea, E-mail: email@example.com
Asian countries consume a traditional diet high in seaweed (1). Brown seaweeds are a potential source of bioactive ingredients. They also contain large amounts (∼40% of dry matter) of polysaccharides, which are considered dietary fibers (2,3). These polysaccharides include laminarin, fucoidan, and alginates. Of these, laminarin is a storage glucan found in brown algae (4), and is composed of β-glucan (β1–3, β1–6-glucan) (5). Due to these characteristics, laminarin is assumed to have biological activities similar to those of other glucans. Glucans are highly functional materials that are FDA-approved for lowering cholesterol. They have been shown to stimulate immunity, and to have antitumor effects and antibacterial activity (6–8). Moreover, they have been studied extensively for their immunological and pharmacological effects. However, the biological activities of laminarin have yet to be investigated. To evaluate its potential inhibition of colon cancer, we evaluated the effects of laminarin in vitro.
Apoptosis is important in the normal development and differentiation of a wide variety of tissues. Apoptosis is characterized by several unique features, including cell shrinkage, chromatin condensation, DNA fragmentation, the cell surface expression of phosphatidylserine, and membrane blebbing (9,10). Predominantly, apoptosis may be initiated in two ways: by an intrinsic (mitochondrial-mediated) or by an extrinsic (death receptor-mediated) pathway (11–13). Each pathway results from the activation of caspases and ultimately leads to apoptosis. In the latter case, transmembrane death receptors are involved and the apoptotic signal occurs by the interaction between the ligands and the death receptor. A wide range of physical and chemical changes of mitochondrial integrity may be triggered by stimulating the intrinsic pathway of apoptosis (11–13). However, most cancer cells block apoptosis, allowing the survival of malignant cells, despite genetical and morphological changes. Fas and FasL are apoptosis-inducing members of the TNF-cytokine family. Fas activation by FasL and its receptor FADD activate caspases-3, -8 and -9, leading to apoptosis (14–16). Thus, we aimed to determine whether laminarin inhibits cell growth and induces apoptosis in colon cancer cells.
Insulin-like growth factor-I receptor (IGF-IR) is significant in cell growth, differentiation, and survival (17). Overexpression of IGF-IR and related proteins results in cancer cell proliferation and survival. Thus, IGF-IR is involved in malignant transformation (18–20). Therefore, IGF-IR and related proteins are attractive anticancer targets.
In the present study, we aimed to determine whether laminarin induced apoptosis by molecular mechanisms involving IGF-IR and cell death pathways. We examined the manner in which laminarin regulates HT-29 cells, and assessed its effect on the Fas and IGF-IR signaling pathways. The results showed that activation of Fas-induced apoptosis blocks the IGF-IR pathway.
Human colon adenocarcinoma cells (ATCC HTB-38) and rat small intestine epithelial cells (IEC-6, ATCC CRL-1592) were obtained from the American Type Culture Collection (Rockville, MD, USA). Cells were maintained in a humidified 5% CO2, 95% air, 37°C environment in RPMI-1640. DMEM was supplemented with penicillin/streptomycin (P/S), and HT-29 and IEC-6 cell cultures were supplemented with 10% fetal bovine serum (HyClone, Inc., South Logan, UT, USA). Cells in the exponential phase were used.
Laminarin (L-9634) was purchased from Sigma-Aldrich (St. Louis, MO, USA). The effects of various laminarin concentrations on the cell proliferation of HT-29 and IEC-6 cells were determined colorimetrically after 24 h using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay with Cell Titer 96® AQueous One Solution Reagent (Promega, Madison, WI, USA). Cells were seeded onto 96-well plates at 2×104 cells/well in 100 μl medium and incubated for 24 h. Attached cells were maintained in serum-free medium (SFM) for 12 h, followed by laminarin treatment (0-5 mg/ml) for 24 h. Subsequently, cells were incubated with MTS solution at 37°C for 30–60 min and the absorbance of each well was measured at 490 nm using a microplate reader. The OD490 values of the control cells were designated as 100%.
Caspase activities were measured using caspase-3 substrate I (Ac-DEVD-pNA; 235400), caspase-8 substrate I (Ac-IETD-pNA) and caspase-3 inhibitor [Z-D(Ome)-E-(Ome)-V-D(OMe)-FMK; 368057; Calbiochem, San Diego, CA, USA]. Cells were seeded in culture dishes and grown to 60% confluence. These cells were treated with 50 μM caspase inhibitor for 1 h and laminarin for 24 h, after which caspase lysis buffer (2.5 mM HEPES, pH 7.5, 5 mM EDTA, 2 mM DTT, 0.1% CHAPS) was added. A total of 100 μg protein/100 μl was collected, and 2 μl of the substrate was added to the wells. Cells were incubated with a caspase substrate in a shaking incubator at 37°C for 4 h. The absorbance at 405 nm was then determined using an ELISA plate reader.
To prepare whole-cell extracts, cells were washed with PBS and suspended in extraction buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.25% Na-deoxycholate, 1% NP-40, and 1 mM EGTA) containing protease inhibitors (1 mM Na3VO4, 1 μg/ml aprotinin, 1 μg/ml pepstatin, 1 μg/ml leupeptin, 1 mM NaF, and 1 mM PMSF) on ice. The extracts were centrifuged at 12,000 rpm for 10 min and the supernatant was used in western blotting. Boiling sample buffer (50 μg/ml) was added to the total cell lysate and the samples were boiled for 10 min at 100°C. Proteins were separated in 7.5–15% SDS-PAGE gels and transferred to PVDF membranes (Millipore, Billerica, MA, USA). Membranes were blocked for 1 h at room temperature in blocking buffer [1% bovine serum albumin (BSA) in TBS-T]. Blots were probed with primary antibodies (1:1,000 in 1% BSA/TBS-T) for 18 h at 4°C. The membranes were then washed twice for 15 min in TBS-T. The secondary antibody was a horseradish peroxidase (HRP)-conjugated goat anti-mouse or rabbit antibody (1:10,000 in 1% BSA/TBS-T). Signal bands were detected using an enhanced chemiluminescence western blotting kit (Amersham Biosciences, Piscataway, NJ, USA).
Multiple mean values were compared by analysis of variance using the SPSS software (SPSS, Inc., Chicago, IL, USA). Values were presented as the means ± standard deviation. P<0.05 was considered statistically significant. Values in Fig. 3, indicated with the letters a-d were significantly different according to the Duncan’s multiple range test.
We determined the effect of 24-h laminarin treatment (0, 1.25, 2.5 and 5 mg/ml) on the viability of HT-29 and IEC-6 cells by MTS assay (Fig. 1). Laminarin treatment decreased the proliferation of HT-29 cells in a dose-dependent manner. Exposure to 5 mg/ml laminarin inhibited cell growth by 60%. By contrast, IEC-6 cells were unaffected. Moreover, no toxicity to either cell type was detected.
The effect of laminarin on cell and nuclear morphology was determined using an MTS assay and light microscopy (Fig. 2). The survival of HT-29 cells was reduced in a laminarin concentration-dependent manner. Cells also decreased in size in a laminarin concentration-dependent manner.
To determine which caspases are activated by laminarin, we identified laminarin-induced enzyme activities (Fig. 3). A significant increase was found in the level of caspase-3, but not caspase-8. We examined caspase-3 activation after laminarin treatment in the presence of a caspase-3 inhibitor. The caspase-3 inhibitor completely blocked caspase-3 activity, suggesting that laminarin activates caspase-3, but not caspase-8.
A wide variety of signaling molecules are combined with cell-surface receptors. Fas (CD95, APO-1), a member of the tumor necrosis factor family, is a cell death receptor that plays a key role in the regulation of homeostasis (21).
Fas and the Fas receptor induce the activation of members of the caspase family, and subsequently the cleavage of markers of apoptosis such as poly (ADP-ribose) polymerase (PARP) (22). This signaling cascade is known as the Fas signaling pathway. Following laminarin treatment, an increase was observed in the expression of FAS and FADD (Fig. 4). We previously reported that laminarin treatment caused caspase-3 activation and PARP cleavage. These results suggest that laminarin induced apoptosis via the Fas signaling pathway.
Laminarin induced apoptosis via the Fas signaling pathway. Cell death signaling mechanisms and cell growth were also affected by laminarin. The growth-inhibitory effect of laminarin was associated with changes in the expression of proteins involved in the IGF-IR pathway in HT-29 cells (Fig. 5). Signaling pathways activated by IGF-IR include the mitogen-activated protein kinases (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways (23). This signaling is controlled by the IGF-binding protein (IGFBP). A decreased expression of the IGF-IR and downstream signaling proteins such as PI3K, PY99, Akt and MAPK IRS-1 inhibits events in cancer. These results suggest that laminarin may inhibit cancer development by regulating the IGF-IR pathway.
We demonstrated that laminarin induces apoptosis in a Fas-mediated manner. In addition, we found that laminarin downregulates IGF-IR-related proteins.
Therefore, we determined whether Fas-induced apoptosis blocks the IGF-IR pathway. In HT-29 cells, pancaspase inhibitor treatment suppressed caspase activation. Results of the western blot analysis showed that inhibitor treatment resulted in decreased caspase-3 levels (data not shown) and the recruitment of PI3K and Akt (Fig. 6). Thus, the IGF-I pathway is involved in laminarin-induced apoptosis.
The anticancer effect of seaweed has been the focus of many recent studies. Seaweed contains large amounts (∼40% of the dry matter) of polysaccharides, primarily laminarin, fucoidan, and alginates. In the present study, we found that laminarin inhibits HT-29 cell growth by decreasing cell proliferation and inducing apoptosis.
To the best of our knowledge, we have provided the first evidence that laminarin regulates apoptosis and the IGF-IR-related protein expression. When HT-29 cells were incubated with laminarin, cell viability was decreased. HT-29 cells treated with laminarin exhibited morphological changes; cells decreased in size in a laminarin concentration-dependent manner.
FasL and its receptor FADD are adapter molecules required for Fas-mediated apoptosis (24,25). Laminarin regulated Fas and FADD protein levels, suggesting that it induces Fas-mediated apoptosis. It also increased the expression of Fas and FADD, which in turn induced the activation of members of the caspase family (26,27). Caspases play a key role in cell death-related apoptosis. We analyzed caspase activation during laminarin-induced apoptosis using caspase substrates. In HT-29 cells, we detected a significant increase in the level of caspase-3, but not caspase-8. Caspase-8 is an initial caspase in apoptosis and is essential to the Fas-mediated apoptosis pathway (28,29). Previous reports have shown that caspase-8 may induce apoptosis independent of Fas. In their study, Feng et al (30) reported that Fas-FADD oligomerization is able to trigger a novel caspase-8-independent pathway.
IGF-I signaling plays a role in cancer development and progression (31,32). Remacle-Bonnet et al (33) showed that IGF-I protected cancer cells against apoptosis. The mechanisms by which IGF-I and IGF-I receptors interact with cell death pathways remain unclear. Therefore, it is important to elucidate the relationships between IGF-I and IGF-I receptors and apoptotic pathways.
We examined the effect of laminarin on the IGF-IR pathway. A decreased expression of IGF-IR and downstream signaling proteins inhibits events in cancer. These results suggest that laminarin inhibits cancer by regulating the IGF-IR pathway. As shown in Figs. 6 and 7, a pancaspase inhibitor suppressed caspase activation in HT-29 cells. This inhibition affected the expression of IGF-I receptor pathway-related proteins. Therefore, we demonstrated that the activation of Fas-induced apoptosis blocks the IGF-IR pathway.
These data suggest that laminarin has the potential to be used as an anticancer agent. Recently, studies have reported anticancer effects of seaweeds (34,35). However, to the best of our knowledge, this is the first report of laminarin activity against human colon cancer cells. Therefore, the regulation of these two pathways may be important for the treatment of human colon cancer and serve as a novel target of anticancer supplements and drugs.
This research was supported by iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea.
|1..||Fuller R. Probiotics in man and animalsJ Appl Bacteriol66365378Year: 19892666378|
|2..||Gibson GR,Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human useJ Nutr130Suppl 2391S395SYear: 200010721913|
|3..||Nisizawa K,Yamaguchi T,Handa N,Maeda M,Yamazaki H. Chemical nature of a uronic acid-containing polysaccharide in the peritrophic membrane of the silkwormJ Biochem54419426Year: 196314089735|
|4..||Michel C,Lahaye M,Bonnet C,Mabeau S,Barry JL. In vitro fermentation by human faecal bacteria of total and purified dietary fibres from brown seaweedsBr J Nutr75263280Year: 19968785203|
|5..||Williams DL. Overview of (1→3)-beta-D-glucan immunobiologyMediators Inflamm6247250Year: 199718472852|
|6..||Cheung NK,Modak S,Vickers A,Knuckles B. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodiesCancer Immunol Immunother51557564Year: 200212384807|
|7..||Williams DL,Mueller A,Browder W. Glucan-based macrophage stimulators: a review of their anti-infective potentialClin Immunother5392399Year: 1998|
|8..||Kim EJ,Lee YJ,Shin HK,Park JHY. A study on the mechanism by which the aqueous extract of Inonotus obliquus induces apoptosis and inhibits proliferation in HT-29 human colon cancer cellsJ Korean Soc Food Sci Nutr35516523Year: 2006|
|9..||Khan N,Adhami VM,Mukhtar H. Apoptosis by dietary agents for prevention and treatment of cancerBiochem Pharmacol7613331339Year: 200818692026|
|10..||Burz C,Berindan-Neagoe I,Balacescu O,Irimie A. Apoptosis in cancer: key molecular signaling pathways and therapy targetsActa Oncol48811821Year: 200919513886|
|11..||Brenner D,Mak TW. Mitochondrial cell death effectorsCurr Opin Cell Biol21871877Year: 200919822411|
|12..||Jeong SY,Seol DW. The role of mitochondria in apoptosisBMB Rep411122Year: 200818304445|
|13..||Mellier G,Huang S,Shenoy K,Pervaiz S. TRAILing death in cancerMol Aspects Med3193112Year: 201019995571|
|14..||Hodge S,Novembre FJ,Whetter L,Gelbard HA,Dewhurst S. Induction of fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14Virology252354363Year: 19989878614|
|15..||Walker PR,Saas P,Dietrich PY. Tumor expression of Fas ligand (CD95L) and the consequencesCurr Opin Immunol10564572Year: 19989794830|
|16..||Freiberg RA,Spencer DM,Choate KA,Peng PD,Schreiber SL,Crabtree GR,Khavari PA. Specific triggering of the Fas signal transduction pathway in normal human keratinocytesJ Biol Chem2713166631669Year: 19968940187|
|17..||Butler AA,Yakar S,Gewolb IH,Karas M,Okubo Y,LeRoith D. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biologyComp Biochem Physiol B Biochem Mol Biol1211926Year: 19989972281|
|18..||Rubini M,Hongo A,D’Ambrosio C,Baserga R. The IGF-1 receptor in mitogenesis and transformation of mouse embryo cells: role of receptor numberExp Cell Res230284292Year: 19979024787|
|19..||Reiss K,Valentinis B,Tu X,Xu SQ,Baserga R. Molecular markers of IGF-I-mediated mitogenesisExp Cell Res242361372Year: 19989665833|
|20..||Butler AA,Blakesley VA,Poulaki V,Tsokos M,Wood TL,LeRoith D. Stimulation of tumor growth by recombinant human insulin-like growth factor I (IGF-I) is dependent on the dose and the level of IGF-I receptor expressionCancer Res5830213027Year: 19989679966|
|21..||Vaux DL,Korsmeyer SJ. Cell death in developmentCell96245254Year: 19999988219|
|22..||Enari M,Talanian RV,Wong WW,Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosisNature380723726Year: 19968614469|
|23..||Dupont J,LeRoith D. Insulin and insulin-like growth factor I receptors: similarities and differences in signal transductionHorm Res55Suppl 2S22S26Year: 2001|
|24..||Chinnaiyan AM,O’Rourke K,Tewari M,Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosisCell81505512Year: 19957538907|
|25..||Nagata S,Golstein P. The Fas death factorScience26714491456Year: 19957533326|
|26..||Kischkel FC,Hellbardt S,Behrmann I,Germer M,Pawlita M,Krammer PH,Peter ME. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptorEMBO J1455795588Year: 19958521815|
|27..||Salvesen GS,Dixit VM. Caspases: intracellular signaling by proteolysisCell91443446Year: 19979390553|
|28..||Varfolomeev EE,Schuchmann M,Luria V,Chiannilkulchai N,Beckmann JS,Mett IL,Rebrikov D,Brodianski VM,Kemper OC,Kollet O,et al. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatallyImmunity9267276Year: 19989729047|
|29..||Juo P,Kuo CJ,Yuan J,Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascadeCurr Biol810011008Year: 19989740801|
|30..||Feng H,Zeng Y,Graner MW,Whitesell L,Katsanis E. Evidence for a novel, caspase-8-independent, Fas death domain-mediated apoptotic pathwayJ Biomed Biotechnol20044151Year: 200415123887|
|31..||Baserga R,Peruzzi F,Reiss K. The IGF-1 receptor in cancer biologyInt J Cancer107873877Year: 200314601044|
|32..||Werner H,LeRoith D. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasiaCell Mol Life Sci57932942Year: 200010950308|
|33..||Remacle-Bonnet MM,Garrouste FL,Heller S,Andre F,Marvaldi JL,Pommier GJ. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathwaysCancer Res6020072017Year: 200010766192|
|34..||Ermakova S,Sokolova R,Kim SM,Um BH,Isakov V,Zvyagintseva T. Fucoidans from brown seaweeds Sargassum hornery, Eclonia cava, Costaria costata: structural characteristics and anticancer activityAppl Biochem Biotechnol164841850Year: 201121302149|
|35..||Namvar F,Mohamed S,Fard SG,Behravan J,Mustapha NM,Alitheen NB,Othman F. Polyphenol-rich seaweed (Eucheuma cottonii) extract suppresses breast tumour via hormone modulation and apoptosis inductionFood Chemistry130376382Year: 2012|
Keywords: laminarin, caspase-3, insulin-like growth factor-IR signaling pathway.
Previous Document: Pathways for C-H bond cleavage of propane ?-complexes on PdO(101).
Next Document: Resect and discard strategy in clinical practice: a prospective cohort study.